The Benefits of Clinical Trials for Triple Negative Breast Cancer

Listen Now

Topics Covered

• The Treatment of Triple Negative Breast Cancer
• Why Clinical Trials are Important as a Treatment Option for Triple Negative Breast Cancer
• What Happens in a Clinical Trial
• Stages of Clinical Trials
• New Research in the Treatment of Triple Negative Breast Cancer (TNBC)
• Investigational New Drugs in Clinical Trials
• The Meaning of Informed Consent
• Benefits & Risks of Participation
• How & Where Clinical Trials are Conducted
• How to Participate in Clinical Trials
• Specific Questions to Ask Your Health Care Team about Clinical Trials
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
• Accessing Resources for Clinical Trials
• Questions for our Panel of Experts

Our Panel of Experts

Marcela Mazo Canola, MD

Assistant Professor of Medicine, Division of Hematology-Oncology, Breast Medical Oncology, UT Health San Antonio Mays Cancer Center

Saba Shaikh, MD

Assistant Professor, Division of Hematology/Oncology UT Health San Antonio, Mays Cancer Center

Arlene Brothers

Interim Executive Director, Triple Negative Breast Cancer Foundation®

Jennifer LaPietra, MSW

Patient Assistance Program Manager, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on February 18, 2026.